Pharmaceutics formulation/chemistry manufacturing and controls consulting services for small molecules and/or biologics
Active Purchase Order Awarded Last action
- Contract number
- 75N95025P00441
- Awardee
-
Araldi Gian Luca UEI R6H9XGXZKML8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $43,710
Award facts
- Opportunity
-
- Subject Matter Expert Consultant for Pharmaceutics / Formulation / Chemistry Manufacturing Control [CMC] Solicitation · 75N95025Q00057 · Posted Aug 8, 2025
- Contract value 100% obligated
- $43,710.00 Current and potential, with all options
- Completion date 55% complete
- Current and potential, with all options
- Funding agency
- National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 10 offers Simplified Acquisition
- Pricing
- Labor Hours
- Place of performance
- San Marcos, CA 92069, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $23,500 | |
| Exercise an Option | $11,750 | |
| Original award | $8,460 |
About this award
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a purchase order to Araldi Gian Luca for $43,710 on September 29, 2025, exercising an option year for pharmaceutics formulation, chemistry manufacturing and controls consulting services. This is a total small business set-aside under FAR Part 13 simplified acquisition procedures.
Performance occurs in San Marcos, California, with remote engagement and optional on-site visits to NIH Bethesda facilities. The contractor provides subject matter expert consulting on drug development processes, regulatory risk assessment, manufacturing strategy recommendations, and regulatory documentation support for small molecules and biologics within NIH Blueprint Neurotherapeutics, HEAL Initiative, and biologics programs. The order runs through September 28, 2027. The underlying solicitation, posted August 8, 2025, required a minimum of 15 years' experience in drug discovery and CMC, an advanced science degree, and demonstrated expertise in neuroscience and pain treatment research. Personnel qualifications were weighted 50 points under best-value technical evaluation.
Quick answers
Who was awarded contract 75N95025P00441?
75N95025P00441 was awarded to Araldi Gian Luca by National Institute on Drug Abuse (National Institutes of Health) on September 29, 2025.
How much is contract 75N95025P00441 worth?
The government has obligated $43,710 on 75N95025P00441.
Which agency awarded contract 75N95025P00441?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95025P00441, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).
Was contract 75N95025P00441 competed?
The extent of competition for 75N95025P00441 was competed under sap. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award